the basis of T/R in the Pro­tocol [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2014-03-14 16:01 (4490 d 04:47 ago) – Posting: # 12629
Views: 9,131

Hi Mittyri,

❝ ❝ If I have information about a larger deviation from a pilot study I use it.

❝ Do you insert any links to the publications about these pilot studies (may be for another market)?


By “pilot” I meant studies the sponsor performed or have access to in an acquired dossier. Only such studies can be assesses for the quality of data (clinical performance, bioanalytics, …). Studies from the literature should be used with caution.

❝ Would you rest the T/R Ratio in the protocol without explanation?


No.

❝ Is it important to the Assessor to know - where do you get this ratio or why are you assuming such ratio?


I think we have to distinguish between assessing the protocol (authority, IEC)* and the report.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
238 visitors (0 registered, 238 guests [including 24 identified bots]).
Forum time: 21:48 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5